Bayrak A Hasanefendioğlu, Numan F, Cantaşdemir M, Baş A
Department of Radiology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey.
Acta Chir Belg. 2008 Nov-Dec;108(6):708-14. doi: 10.1080/00015458.2008.11680321.
To investigate effectiveness of percutaneous transluminal renal angioplasty (PTRA) in treatment of renal artery stenoses due to Takayasu arteritis (TA), fibromuscular dysplasia (FMD) and neurofibromatosis (NF).
MATERIALS-METHODS: Between December 1991-October 2006, 20 pediatric cases (age range 3-18 years, meanly 12.5 year) with at least 60% stenoses were underwent PTRA. Main presenting symptom was hypertension. The aetiologies were TA in 12, and FMD in 5, NF in three cases.
Totally, 46 procedures were performed on 35 stenotic segments of 20 cases. A technically good result was obtained in 21/24 arteries of TA patients, 7/7 arteries of FMD patients, and 1/3 arteries of NF1 patients. Clinical followup for a mean of 55.7 months revealed 100% success in all cases. Delayed clinical response was seen in two cases with NF1. Restenosis was detected 5/12 of TA patients, 1/5 of FMD patients and 1/3 NF1 patients.
PTRA can be safely performed resulting in excellent angiographic and clinical results. It should be first choice in renal artery stenosis in pediatric age when medical treatment fails to control renovascular hypertension or renal function is decreasing although initial results might be not encouraging in NF1.
探讨经皮腔内肾血管成形术(PTRA)治疗大动脉炎(TA)、纤维肌性发育异常(FMD)和神经纤维瘤病(NF)所致肾动脉狭窄的有效性。
1991年12月至2006年10月期间,对20例年龄在3 - 18岁(平均12.5岁)、肾动脉狭窄至少60%的儿科患者进行了PTRA。主要临床表现为高血压。病因包括TA 12例、FMD 5例、NF 3例。
共对20例患者的35个狭窄节段进行了46次手术。TA患者24条动脉中有21条技术效果良好,FMD患者7条动脉全部良好,NF1患者3条动脉中有1条良好。平均55.7个月的临床随访显示所有病例成功率为100%。2例NF1患者出现延迟临床反应。TA患者中有5/12发生再狭窄,FMD患者中有1/5,NF1患者中有1/3。
PTRA可安全实施,血管造影和临床效果良好。在儿科患者肾动脉狭窄时,当药物治疗无法控制肾血管性高血压或肾功能下降时,PTRA应作为首选,尽管NF1患者的初始结果可能不乐观。